Amitriptyline in Depressive States
- 1 November 1963
- journal article
- research article
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 109 (463) , 826-829
- https://doi.org/10.1192/bjp.109.463.826
Abstract
Amitriptyline, 5-(3 dimethylaminopropylidine)-dibenzo (a,d) (1,4) cycloheptadicne hydrochloride, though chemically and pharmacologically related to imipramine (Barsa and Saunders, 1961) has a tranquillizing effect which is absent with imipramine (Pressman and Weiss, 1961; Bennett, 1961); it acts simultaneously as an antidepressant through its influence on the “anxiety factor” (Freed, 1960; Dorfman, 1960). In contrast to imipramine and the monoamine oxidase inhibitors, amitriptyline has very little influence on the circulatory system and blood pressure (Jensen, 1961) and less proneness to exacerbate the symptoms of schizophrenia (Barsa and Saunders, 1961). Dunlop (1961) noticed a reduction in other symptoms, such as gastrointestinal distress, hyperventilation and vasomotor dysfunction for which amitriptyline was not primarily administered. This he attributed to an anticholinergic side-effect on the central nervous system.Keywords
This publication has 6 references indexed in Scilit:
- AMITRIPTYLINE IN DEPRESSIONThe Lancet, 1961
- AMITRIPTYLINE (ELAVIL), A NEW ANTIDEPRESSANTAmerican Journal of Psychiatry, 1961
- ON THE PARENTERAL USE OF AMITRIPTYLINE (ELAVIL–MERCK): A PRELIMINARY REPORTAmerican Journal of Psychiatry, 1960
- THE MODERN TREATMENT OF DEPRESSIVE DISORDERSAmerican Journal of Psychiatry, 1960
- Editorial: A Review of a Book ReviewPsychosomatics, 1960
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960